Abstract

There is growing evidence that chronic hyperglycemia leads to the formation of advanced glycation end products (AGEs) which exerts its effect via interaction with the receptor for advanced glycation end products (RAGE). AGE-RAGE activation results in oxidative stress and inflammation. It is well known that this mechanism is involved in the pathogenesis of cardiovascular disease in diabetes. Kaempferol, a dietary flavonoid, is known to possess antioxidant, anti-apoptotic, and anti-inflammatory activities. However, little is known about the effect of kaempferol on myocardial ischemia-reperfusion (IR) injury in diabetic rats. Diabetes was induced in male albino Wistar rats using streptozotocin (70 mg/kg; i.p.), and rats with glucose level >250 mg/dL were considered as diabetic. Diabetic rats were treated with vehicle (2 mL/kg; i.p.) and kaempferol (20 mg/kg; i.p.) daily for a period of 28 days and on the 28th day, ischemia was produced by one-stage ligation of the left anterior descending coronary artery for 45 min followed by reperfusion for 60 min. After completion of surgery, rats were sacrificed and the heart tissue was processed for biochemical, morphological, and molecular studies. Kaempferol pretreatment significantly reduced hyperglycemia, maintained hemodynamic function, suppressed AGE-RAGE axis activation, normalized oxidative stress, and preserved morphological alterations. In addition, there was decreased level of inflammatory markers (tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), and NF-κB), inhibition of active c-Jun N-terminal kinase (JNK) and p38 proteins, and activation of Extracellular signal regulated kinase 1/2 (ERK1/2) a prosurvival kinase. Furthermore, it also attenuated apoptosis by reducing the expression of pro-apoptotic proteins (Bax and Caspase-3), Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) positive cells, and increasing the level of anti-apoptotic protein (Bcl-2). In conclusion, kaempferol attenuated myocardial ischemia-reperfusion injury in diabetic rats by reducing AGE-RAGE/ mitogen activated protein kinase (MAPK) induced oxidative stress and inflammation.

Highlights

  • The morbidity and mortality due to myocardial infarction remains high especially in diabetic patients, despite the availability of numerous therapeutic modalities [1]

  • One rat died from the diabetic-control, three rats from diabetes + IR, and one rat from the treatment group

  • Sci. 2017, 18, 1001 glutathione (GSH), superoxide dismutase (SOD), and catalase (CAT)) and from the remaining three rats, a half part of the heart removed was used for Western blot analysis and the other half was used for histopathology, ultrastructural, and Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) analysis

Read more

Summary

Introduction

The morbidity and mortality due to myocardial infarction remains high especially in diabetic patients, despite the availability of numerous therapeutic modalities [1]. The mechanism by which AGE produces its effect in the pathogenesis of cardiovascular disease has been postulated to be direct as well as indirect. The indirect effect of AGE involves its interaction with the receptor for advanced glycation end products (RAGE). The expression of RAGE is low, in diseased states such as diabetes, inflammation, and cardiovascular pathology, there is an increased expression of RAGE [7]. Bucciarelli along with his colleagues demonstrated that cardiac IR led to the up regulation of RAGE [8]. Tikellis et al (2008) investigated the relationship between RAGE and oxidative stress in vivo and showed that RAGE-deficient mice displayed reduced markers of oxidative stress [10]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call